These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3097059)

  • 41. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
    Devesa J; Arce V; Lois N; Tresguerres JA; Lima L
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1581-8. PubMed ID: 1977761
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impaired growth hormone (GH) response to GH-releasing hormone in thalassemia major.
    Pintor C; Cella SG; Manso P; Corda R; Dessĭ C; Locatelli V; Müller EE
    J Clin Endocrinol Metab; 1986 Feb; 62(2):263-7. PubMed ID: 3079770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.
    Alvarez-Castro P; Isidro ML; Garcia-Buela J; Leal-Cerro A; Broglio F; Tassone F; Ghigo E; Dieguez C; Casanueva FF; Cordido F
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):250-5. PubMed ID: 15272922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of overnight constant infusion of human growth hormone (GH)-releasing hormone-(1-44) on 24-hour GH secretion in children with partial GH deficiency.
    Rochiccioli PE; Tauber MT; Uboldi F; Coude FX; Morre M
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1100-5. PubMed ID: 3093519
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
    Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measurement of growth hormone-releasing hormone and somatostatin in hypothalamic-portal plasma of unanesthetized sheep. Spontaneous secretion and response to insulin-induced hypoglycemia.
    Frohman LA; Downs TR; Clarke IJ; Thomas GB
    J Clin Invest; 1990 Jul; 86(1):17-24. PubMed ID: 1973173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.
    Corpas E; Harman SM; Piñeyro MA; Roberson R; Blackman MR
    J Clin Endocrinol Metab; 1992 Aug; 75(2):530-5. PubMed ID: 1379256
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency.
    Colao A; Cerbone G; Pivonello R; Aimaretti G; Loche S; Di Somma C; Faggiano A; Corneli G; Ghigo E; Lombardi G
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1277-82. PubMed ID: 10199767
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Repetitive injections of growth hormone releasing hormone (GHRH1-44) to normal volunteers and patients with growth hormone deficiency.
    Hümmelink R; Sippell WG
    Horm Metab Res; 1990 Feb; 22(2):101-8. PubMed ID: 2182500
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence for an inhibitory effect of physiological levels of insulin on the growth hormone (GH) response to GH-releasing hormone in healthy subjects.
    Lanzi R; Manzoni MF; Andreotti AC; Malighetti ME; Bianchi E; Sereni LP; Caumo A; Luzi L; Pontiroli AE
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2239-43. PubMed ID: 9215300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man.
    Giustina A; Girelli A; Doga M; Bodini C; Bossoni S; Romanelli G; Wehrenberg WB
    J Clin Endocrinol Metab; 1990 Sep; 71(3):580-4. PubMed ID: 2118535
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine.
    Valcavi R; Valente F; Dieguez C; Zini M; Procopio M; Portioli I; Ghigo E
    J Clin Endocrinol Metab; 1993 Sep; 77(3):616-20. PubMed ID: 8103770
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.
    Ghigo E; Gianotti L; Arvat E; Ramunni J; Valetto MR; Broglio F; Rolla M; Cavagnini F; Müller EE
    J Clin Endocrinol Metab; 1999 Jan; 84(1):285-90. PubMed ID: 9920097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The somatostatin analog octreotide inhibits the secretion of growth hormone (GH)-releasing hormone, thyrotropin, and GH in man.
    Masuda A; Shibasaki T; Kim YS; Imaki T; Hotta M; Demura H; Ling N; Shizume K
    J Clin Endocrinol Metab; 1989 Oct; 69(4):906-9. PubMed ID: 2506217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma levels of growth hormone-releasing hormone and somatostatin in response to a mixed meal and during sleep in children.
    Rosskamp R; Becker M; Haverkamp F; Thomas B; Brühl S; Klumpp J; Liappis N
    Acta Endocrinol (Copenh); 1987 Dec; 116(4):549-54. PubMed ID: 2892332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma GH response to the sequential 3 day administrations of GHRH followed by arginine infusion in patients with idiopathic GH deficiency and normal short children.
    Hanew K; Utsumi A; Sugawara A; Shimizu Y; Tazawa S; Abe K
    Tohoku J Exp Med; 1993 Feb; 169(2):91-101. PubMed ID: 8236247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GHRH and TRH tests in patients with idiopathic and secondary GH deficiency--with special reference to GH response patterns to GHRH.
    Hanew K; Sugawara A; Utsumi A; Shimizu Y; Yoshinaga K
    Tohoku J Exp Med; 1990 Mar; 160(3):189-202. PubMed ID: 2112793
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calcitonin suppresses growth hormone (GH) response to growth hormone-releasing hormone (GHRH) in man.
    Lengyel AM; Toledo AL; Czepielewski MA; Vieira JG; Chacra AR
    J Endocrinol Invest; 1989 Jan; 12(1):25-9. PubMed ID: 2545765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The growth hormone releasing hormone (GHRH) response to a mixed meal is blunted in young adults with insulin-dependent diabetes mellitus whereas the somatostatin response is normal.
    Foot AB; Davidson K; Edge JA; Wass JA; Dunger DB
    Clin Endocrinol (Oxf); 1990 Feb; 32(2):177-83. PubMed ID: 1971774
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of oral glucose on the late growth hormone rise and growth hormone responses to GHRH in normal subjects.
    Valcavi R; Zini M; Dieguez C; Portioli I; Scanlon MF
    Clin Endocrinol (Oxf); 1990 May; 32(5):539-43. PubMed ID: 2114240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.